drugset / Trial / NCT00006486
Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer
RandomizedParallel-groupDouble-blindTreatment
Summary
Randomized phase II trial to study the effectiveness of carboxyamidotriazole in treating patients who have metastatic kidney cancer. Carboxyamidotriazole may stop the growth of kidney cancer by stopping blood flow to the tumor
Timeline
- Start
- 2000-10
- Primary completion
- 2005-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | carboxyamidotriazole | Other / unclassified | — | Oral |